Evidence map›Paper›PMID 20066477›Full record

ArticleMolecular and cellular biochemistry2010

ErbB4 signals Neuregulin1-stimulated cell proliferation and c-fos gene expression through phosphorylation of serum response factor by mitogen-activated protein kinase cascade.

Ko Eto, Asuka Hommyo, Rie Yonemitsu, Shin-Ichi Abe

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ko EtoDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan. etoko@gpo.kumamoto-u.ac.jp
Asuka Hommyo
Rie Yonemitsu
Shin-Ichi Abe
Kumamoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ErbB family of tyrosine kinase receptors mediates a variety of cellular responses to Neuregulin (NRG) 1; however, the intracellular signaling pathways downstream of ErbB4 and their functional outcomes remained to be elucidated. Here we show that NRG1 stimulated the proliferation of human HeLa cells expressing ErbB4, where the phosphorylation relay of extracellular signal-regulated kinase, a mitogen-activated protein kinase (MAPK), and serum response factor (SRF), a transcription factor, was induced, and the c-fos transcription was activated. By contrast, these all were attenuated in cells transfected with an ErbB4 mutant substituting the green fluorescence protein for the intracellular domain. We also demonstrated that a MAPK kinase inhibitor suppressed the NRG1-stimulated SRF phosphorylation, c-fos expression, and cell proliferation. Thus, the current study may unravel an ErbB4-mediated signaling pathway that is responsible for the NRG1-induced c-fos gene expression through the MAPK cascade-dependent SRF phosphorylation and thereby cell proliferation.

Indexed as

Cell ProliferationBlotting, WesternErbB ReceptorsHeLa CellsHumansMitogen-Activated Protein KinasesNeuregulin-1PhosphorylationProto-Oncogene Proteins c-fosReceptor, ErbB-4Reverse Transcriptase Polymerase Chain ReactionRNA, MessengerSerum Response FactorSignal TransductionERBB4 protein, humanErbB ReceptorsMitogen-Activated Protein KinasesNeuregulin-1Proto-Oncogene Proteins c-fosReceptor, ErbB-4RNA, MessengerSerum Response Factor

Identifiers

PMID20066477
OpenAlexW2001884780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.